A small subset of IMT that are negative for ALK rearrangement harbor alternative ROS1 fusions (as can occur in lung adenocarcinomas) and are positive for ROS1 immunohistochemistry. The gene discussed is ALK; the disease is inflammatory myofibroblastic tumor.